Growth and maintenance of skeletal muscle mass is critical for long-term health and quality of life. Muscle is important for mobility but it is also crucial for metabolic health because of its contribution to glucose uptake and fat metabolism. Our lab and others have demonstrated that signaling through the mammalian target of rapamycin (mTOR) is necessary for skeletal muscle growth but the molecular links between signal input and downstream function are far from understood. In our previous studies we showed that a) prolonged activation of mTOR signaling is specific to growth inducing contractions, b) mechanical strain activates mTOR signaling in skeletal muscle but not in non-muscle cells, c) strain-induced mTOR signaling is independent of the IGFl/insulin/PI3 kinase signaling pathways, and d) cell cycle genes, such as cyclin D1 and c-myc, are induced during mTOR dependent growth and they likely function, in the differentiated muscle cell, to induce ribosomal biogenesis/protein synthesis. The overall goal of this research is to use in vitro and in vivo models of skeletal muscle growth with molecular tools to identify the necessary upstream regulators and downstream effectors of mTOR. I) mechanical strain acts synergistically with IGF1 to prolong activation of mTOR signaling and II) mTOR kinase activity is necessary for translational-regulation of critical growth mRNAs including cyclin D1 and c- myc. These hypotheses will be tested by the following specific aims:
Specific Aim 1. To determine the molecular signals by which mechanical strain regulates mTOR signaling.
Specific Aim 2. To demonstrate whether mechanical signaling acts synergistically with IGF1 to regulate growth-related mTOR function.
Specific Aim 3. Specific Aim 3. To determine whether the kinase activity of mTOR is necessary for growth, protein synthesis and increased c-myc and cyclin D1 protein levels in response to mechanical overload in vivo. The results of these studies will provide novel insight for the field of mTOR regulation and the role of mechanical strain in the growth process of skeletal muscle. The clinical implications of this work are also significant and will contribute to development of strategies to attenuate or ameliorate muscle atrophy associated with disuse, aging, bed rest and cachexia. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR045617-07
Application #
7393339
Study Section
Special Emphasis Panel (ZRG1-MOSS-H (02))
Program Officer
Boyce, Amanda T
Project Start
1999-02-05
Project End
2012-02-29
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
7
Fiscal Year
2008
Total Cost
$305,188
Indirect Cost
Name
University of Kentucky
Department
Physiology
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Chaillou, Thomas; Jackson, Janna R; England, Jonathan H et al. (2015) Identification of a conserved set of upregulated genes in mouse skeletal muscle hypertrophy and regrowth. J Appl Physiol (1985) 118:86-97
Chaillou, Thomas; Lee, Jonah D; England, Jonathan H et al. (2013) Time course of gene expression during mouse skeletal muscle hypertrophy. J Appl Physiol (1985) 115:1065-74
Srikuea, Ratchakrit; Zhang, Xiping; Park-Sarge, Ok-Kyong et al. (2012) VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 303:C396-405
McCarthy, John J; Mula, Jyothi; Miyazaki, Mitsunori et al. (2011) Effective fiber hypertrophy in satellite cell-depleted skeletal muscle. Development 138:3657-66
Drummond, Micah J; McCarthy, John J; Sinha, Mala et al. (2011) Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol Genomics 43:595-603
Miyazaki, Mitsunori; McCarthy, John J; Fedele, Mark J et al. (2011) Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. J Physiol 589:1831-46
Mavalli, Mahendra D; DiGirolamo, Douglas J; Fan, Yong et al. (2010) Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Invest 120:4007-20
McCarthy, John J; Esser, Karyn A (2010) Anabolic and catabolic pathways regulating skeletal muscle mass. Curr Opin Clin Nutr Metab Care 13:230-5
Esser, Karyn A; McCarthy, John J; Miyazaki, Mitsunori (2010) Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is not key for adult skeletal muscle hypertrophy. J Appl Physiol 108:1830
Miyazaki, Mitsunori; McCarthy, John J; Esser, Karyn A (2010) Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes. FEBS J 277:2180-91

Showing the most recent 10 out of 36 publications